Emerge
Posts
🚀 Stocks rise on temporary tariff deal between US and China

🚀 Stocks rise on temporary tariff deal between US and China

Liam Gill
May 13, 2025

Market Overview
Read time 1.4 minutes

Year To Date Performances:

Dow Jones	42,282.38	-0.62%
S&P 500	5,807.42	-1.26%
Nasdaq	18,552.67	-3.93%
Russell 2000	2,023.07	-9.29%
TSX	25,357.74	2.55%
Bitcoin	$103,825.70	12.39%
Ethereum	$2,557.32	-23.20%
US to Canadian Dollar	$1.40	-2.85%

U.S. stocks soared Monday after a surprise U.S.-China agreement to slash tariffs by 115% for 90 days. The deal calmed markets rattled by escalating trade tensions; the Dow jumped 1,021 points (2.5%), the S&P 500 rose 2.9%, and the Nasdaq surged 4%, fueled by gains in tech and semiconductor stocks like Amazon (+8%), Apple (+5%), and On Semiconductor (+10%). Treasury Secretary Scott Bessent called the talks “very productive” and signaled further negotiations are coming, while investors welcomed signs that trade uncertainty may be easing, though experts like UBS’s Kurt Reiman warn market volatility will likely persist.
President Trump on Monday revived his “most favored nation” policy via executive order, aiming to slash U.S. drug prices by tying them to lower international rates—potentially cutting costs by “59%, PLUS!” according to Trump, though experts remain skeptical. The sweeping directive targets drugs with the highest spending and largest global price gaps (like GLP-1s for diabetes and weight loss), expands potential imports beyond Canada, and threatens rulemaking if drugmakers don’t voluntarily lower prices. Shares of Eli Lilly, Pfizer, Merck, and J&J dropped on the news, and industry groups warn the policy could stifle innovation and profitability. Still, Trump is doubling down, also preparing tariffs on imported drugs and leaning on Medicare’s new power to negotiate prices as pressure builds to curb America’s soaring prescription costs.
Could This Company Do for Housing What Tesla Did for Cars? BOXABL believes they have the potential to disrupt a massive and outdated trillion dollar building construction market by bringing assembly line automation to the home industry. Since securing their initial prototype order from SpaceX and a subsequent project order of 156 homes from the Department of Defense, BOXABL has raised over $170M from over 40,000 investors since 2020. They recently achieved a significant milestone: raising over 50% of their Reg A+ funding limit! BOXABL is now only accepting investment on their website until the Reg A+ is full. Invest now before it’s too late. *
Shares of healthcare firm KindlyMD surged over 600% after announcing a surprise merger with Nakamoto Holdings, a bitcoin investment company led by Trump crypto advisor David Bailey. The deal, backed by $710 million in fresh funding—including $510 million via a PIPE offering—brings together a holistic health provider focused on opioid addiction with a crypto treasury strategy modeled after MicroStrategy’s. High-profile investors like Adam Back, Balaji Srinivasan, Jihan Wu, and Ricardo Salinas joined the raise, betting on Bailey’s vision of bitcoin as a standard asset on corporate balance sheets. While the combined company plans to rebrand, KindlyMD says it will continue its addiction treatment services under CEO Tim Pickett.
Headlines
1. Fox will launch a new streaming service, Fox One, before the NFL season.
2. Donald Trump will reportedly be accepting a jet as a gift from Qatar. The jet will be used as Air Force One during his presidency before being gifted to his presidential library after his presidency.
_{* Disclosure: This is a paid advertisement for BOXABL’s Regulation A offering.}_{Please read the offering circular here}_{. This is a message from BOXABL.}

Are you looking to grow your business? Here is how I can help:

📱Book a Strategy Call to get 1:1 feedback on your pitch, pitch deck and/or fundraising strategy. (If you need general startup advice, then reply to this email, and I’ll let you know if/how I can help.)